Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Dewolf

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Urology|February 25, 2000
Is low serum free testosterone a marker for high grade prostate cancer?M A Hoffman, W C DeWolf, A Morgentaler
The Journal of Urology|September 8, 2001
Salvage intravesical therapy with interferon-alpha 2b plus low dose bacillus Calmette-Guerin is effective in patients with superficial bladder cancer in whom bacillus Calmette-Guerin alone previously failedM A O'Donnell, J Krohn, W C DeWolf
The Journal of Urology|February 1, 1975
Congenital hypoplasia of the proximal ureterW C Dewolf, E E Fraley, C Markland
JAMA|December 18, 1996
Occult prostate cancer in men with low serum testosterone levelsA Morgentaler, C O Bruning, W C DeWolf
Urology|June 1, 1996
Ureteral pseudodiverticulosis: the case for the retrograde urogramS A Socher, W C Dewolf, A Morgentaler
Human Pathology|July 1, 1980
HLA and disease: current conceptsW C DeWolf, B Dupont, E J Yunis
The Journal of Urology|July 1, 1995
Distinct glycoforms of a tumor specific glycoprotein, gp200, in human testis and testicular tumorsM Grégoire, W M Schopperle, W C DeWolf
The Journal of Urology|September 1, 1975
Emphysematous pyelonephritis: report of 3 cases treated by nephrectomyS R Dunn, W C Dewolf, R Gonzalez
Archives of Biochemistry and Biophysics|November 1, 1992
Purification of a tumor-specific PNA-binding glycoprotein, gp200, from a human embryonal carcinoma cell lineW M Schopperle, D R Armant, W C DeWolf
BJU International|June 10, 2000
Early catheter removal in 100 consecutive patients undergoing radical retropubic prostatectomyW F Santis, M A Hoffman, W C Dewolf
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Urology|February 25, 2000
Is low serum free testosterone a marker for high grade prostate cancer?M A Hoffman, W C DeWolf, A Morgentaler
The Journal of Urology|September 8, 2001
Salvage intravesical therapy with interferon-alpha 2b plus low dose bacillus Calmette-Guerin is effective in patients with superficial bladder cancer in whom bacillus Calmette-Guerin alone previously failedM A O'Donnell, J Krohn, W C DeWolf
The Journal of Urology|February 1, 1975
Congenital hypoplasia of the proximal ureterW C Dewolf, E E Fraley, C Markland
JAMA|December 18, 1996
Occult prostate cancer in men with low serum testosterone levelsA Morgentaler, C O Bruning, W C DeWolf
Urology|June 1, 1996
Ureteral pseudodiverticulosis: the case for the retrograde urogramS A Socher, W C Dewolf, A Morgentaler
Human Pathology|July 1, 1980
HLA and disease: current conceptsW C DeWolf, B Dupont, E J Yunis
The Journal of Urology|July 1, 1995
Distinct glycoforms of a tumor specific glycoprotein, gp200, in human testis and testicular tumorsM Grégoire, W M Schopperle, W C DeWolf
The Journal of Urology|September 1, 1975
Emphysematous pyelonephritis: report of 3 cases treated by nephrectomyS R Dunn, W C Dewolf, R Gonzalez
Archives of Biochemistry and Biophysics|November 1, 1992
Purification of a tumor-specific PNA-binding glycoprotein, gp200, from a human embryonal carcinoma cell lineW M Schopperle, D R Armant, W C DeWolf
BJU International|June 10, 2000
Early catheter removal in 100 consecutive patients undergoing radical retropubic prostatectomyW F Santis, M A Hoffman, W C Dewolf
Pageof 9